Drugs / Curcuminoid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04890704 | Oct 2018 → Mar 2019 | acute kidney injury, chronic kidney disease, poisoning | Bangkok Metropolitan Administration Medical College and Vajira Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Curcuminoid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04890704 ↗ |
| Known as | Anti-ox | “Curcuminoids (250 mg capsules) were purchased from the Government Pharmaceutical Organization of Thailand (Anti-ox® registration number 1A 1/60(H)), which contained curcumin:...” NCT04890704 ↗ |
| Known as | Curcuminoids | “Curcuminoids (250 mg capsules) were purchased from the Government Pharmaceutical Organization of Thailand (Anti-ox® registration number 1A 1/60(H)), which contained curcumin:...” NCT04890704 ↗ |